ES8102108A1 - Procedimiento para preparar una composicion antitumoral que contiene como ingrediente activo una sal del acido tiazoli- din-4-carboxilico. - Google Patents

Procedimiento para preparar una composicion antitumoral que contiene como ingrediente activo una sal del acido tiazoli- din-4-carboxilico.

Info

Publication number
ES8102108A1
ES8102108A1 ES487052A ES487052A ES8102108A1 ES 8102108 A1 ES8102108 A1 ES 8102108A1 ES 487052 A ES487052 A ES 487052A ES 487052 A ES487052 A ES 487052A ES 8102108 A1 ES8102108 A1 ES 8102108A1
Authority
ES
Spain
Prior art keywords
thiazolidine
carboxylic acid
tumors
treatment
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES487052A
Other languages
English (en)
Other versions
ES487052A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of ES8102108A1 publication Critical patent/ES8102108A1/es
Publication of ES487052A0 publication Critical patent/ES487052A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UNA COMPOSICION ANTITUMORAL, CUYO INGREDIENTE ACTIVO ES UNA SAL DE ACIDO TIAZOLIDIN-4-CABOXILICO, DE FORMULA (I), DONDE X ES UN CATION DE SODIO, POTASIO, CALCIO O MAGNESIO Y N ES SU VALENCIA. LAS FASES DEL PROCEDIMIENTO DE PREPARACION SON SECUENCIALMENTE LAS SIGUIENTES: NEUTRALIZACION DE UNA SOLUCION ACUOSA DEL ACIDO TIAZOLIDIN-4-CARBOXILICO CON UNA BASE EN PRESENCIA DE UN AGENTE DE LIOFILIZACION; FILTRADO, CON PROTECCION DE LA LUZ, DE LA SOLUCION RESULTANTE; LIOFILIZACION DE LA SOLUCION DE LA SAL OBTENIDA, Y ENVASADO DE DICHO POLVO EN UN VIAL. FINALMENTE PUEDE SER TRATADO PARA CONSEGUIR LA PRESENTACION FARMACEUTICA ADECUADA. *FORMULA*
ES487052A 1978-12-21 1979-12-19 Procedimiento para preparar una composicion antitumoral que contiene como ingrediente activo una sal del acido tiazoli- din-4-carboxilico. Granted ES487052A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/971,729 US4384001A (en) 1978-12-21 1978-12-21 Treatment of tumors with thiazolidine-4-carboxylic acid

Publications (2)

Publication Number Publication Date
ES8102108A1 true ES8102108A1 (es) 1980-12-16
ES487052A0 ES487052A0 (es) 1980-12-16

Family

ID=25518727

Family Applications (1)

Application Number Title Priority Date Filing Date
ES487052A Granted ES487052A0 (es) 1978-12-21 1979-12-19 Procedimiento para preparar una composicion antitumoral que contiene como ingrediente activo una sal del acido tiazoli- din-4-carboxilico.

Country Status (16)

Country Link
US (1) US4384001A (es)
JP (1) JPS55115822A (es)
AU (1) AU5390579A (es)
BE (1) BE880744A (es)
CA (1) CA1149284A (es)
DE (1) DE2951050A1 (es)
DK (1) DK542979A (es)
ES (1) ES487052A0 (es)
FR (1) FR2444459A1 (es)
GB (1) GB2039736B (es)
IL (1) IL58948A0 (es)
IT (1) IT1193348B (es)
LU (1) LU82013A1 (es)
NL (1) NL7909199A (es)
SE (1) SE7910300L (es)
ZA (1) ZA796918B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE53332B1 (en) * 1980-03-14 1988-10-26 Efamol Ltd Pharmaceutical compositions
JPS57128625A (en) * 1981-01-30 1982-08-10 Rikagaku Kenkyusho Carcinostatic
US4335210A (en) * 1981-02-11 1982-06-15 Cornell Research Foundation Method of producing L-cysteine
FR2547728B1 (fr) * 1983-06-24 1986-05-02 Riker Laboratories Inc Medicament a base d'acide d thiazolidine carboxylique
FR2547729B1 (fr) * 1983-06-24 1986-05-02 Riker Laboratories Inc Medicament a base d'acide dl thiazolidine carboxylique
JPS62501769A (ja) * 1984-12-18 1987-07-16 デイビツト　ラビン 細胞毒性アルデヒドとベニシラミンとの反応性成物を含有する抗腫瘍組成物及びその使用方法
JPH066578B2 (ja) * 1985-12-27 1994-01-26 三共株式会社 チアゾリジン誘導体
JPH01170063U (es) * 1988-05-11 1989-11-30
JPH0467539U (es) * 1990-10-18 1992-06-16
DE69214467T3 (de) * 1991-01-10 2000-09-28 Transcend Therapeutics Inc Verwendung von L-2-oxo Thiazolidin-4-carboxylat zur Behandlung von Atemnotsyndrom
ES2277787B1 (es) * 2006-01-02 2008-06-16 Universidad De Cadiz Empleo de tioprolina en tratamientos de reduccion de peso corporal.

Also Published As

Publication number Publication date
FR2444459B1 (es) 1983-04-01
NL7909199A (nl) 1980-06-24
BE880744A (fr) 1980-06-19
FR2444459A1 (fr) 1980-07-18
SE7910300L (sv) 1980-06-22
GB2039736B (en) 1983-04-13
AU5390579A (en) 1980-06-26
DE2951050A1 (de) 1980-07-10
IL58948A0 (en) 1980-03-31
IT1193348B (it) 1988-06-15
CA1149284A (en) 1983-07-05
US4384001A (en) 1983-05-17
ZA796918B (en) 1980-11-26
IT7928170A0 (it) 1979-12-18
ES487052A0 (es) 1980-12-16
JPS55115822A (en) 1980-09-06
JPS6328045B2 (es) 1988-06-07
DK542979A (da) 1980-06-22
GB2039736A (en) 1980-08-20
LU82013A1 (fr) 1981-02-03

Similar Documents

Publication Publication Date Title
EP0147761A3 (en) Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
GB2013495A (en) Therapeutic method for the treatment of hyperlipodaemias and hyperlipoproteinaemias
EP0013983A3 (en) Antineoplastics on the basis of little or non-irritating diterpenalcohols,and derivatives thereof, and their preparation
ES8102108A1 (es) Procedimiento para preparar una composicion antitumoral que contiene como ingrediente activo una sal del acido tiazoli- din-4-carboxilico.
DE3163363D1 (en) Mixture for medical semi-rigid supporting bandages, medical bandages obtained therewith and method of making them
HUT44244A (en) Process for preparing isoxazoles inhibiting transglutaminase
NO792346L (no) Fremgangsmaate til syrebehandling av en poroes underjordisk formasjon og gelert, sur sammensetning for bruk ved fremgangsmaaten
EP0004680A3 (en) Pharmaceutical compositions, method of inhibiting and of treating cancerous tumours, and a nonatetraenoic acid
ES8400240A1 (es) "un procedimiento perfeccionado para preparar una composicion solida que contiene bismuto".
DE3478749D1 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
PH14883A (en) A method of treating tumor at administering a derivative of para-aminobenzoic acid
JPS51124130A (en) Treatment of surface of body in water
GB1534238A (en) Composition for treating leukemia and ascites tumour
JPS51116092A (en) Footwear for automatically treating defecation of seriously limbs handicapped patient or the like
DE2964492D1 (en) Use of dispersions of polymers of conjugated dienes, allylsulfonic acids and acrylic acid derivatives for treating leather
EP0286802A3 (en) Use of ofloxacin in treating or preventing locally periodontal disease
JPS539757A (en) Production of taunorbicine derivatives and pharmaceutical composition for treating tumor of human
DE69232852T2 (de) Verwendung von topotecan in der behandlung von nichtkleinzelligen lungenkarzinomen
ES481109A1 (es) Un metodo de preparacion de un extracto de stephania cepha- rantha.
SE7702251L (sv) Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanol
EG12657A (en) Process for preparing of soluble silznols in biologically active water
JPS525755A (en) Process for preparation of 3-amino-4-homotwistane and its acid salts
SU1042752A1 (ru) Способ лечени хронических уретритов у мужчин
JPS554348A (en) Drug composition for treating variety of illness by influence to reticuloendotherial tissue and method of treating maligmant tumor with said composition in treating human
FR2150758A1 (en) Lanthanide oxides - for treatment of cancer